"MATCH": Multi-Antigen T-Cell Engagers
Oncotherapy
Multi-Specific Immunotherapy by Predictive Modeling
High-Throughput Bispecific Antibody Screening
MATCH provides a platform targeting system capable of treating B-cell leukemias, lymphomas, and multiple myeloma through multi-specific targeting.
High-Throughput Bispecific Antibody Screening
Multi-Specific Immunotherapy by Predictive Modeling
High-Throughput Bispecific Antibody Screening
MATCH is a platform capable of producing any bispecific combination of antibody binding fragments.
Multi-Specific Immunotherapy by Predictive Modeling
Multi-Specific Immunotherapy by Predictive Modeling
Multi-Specific Immunotherapy by Predictive Modeling
Thera-T is developing predictive dose models to usher in a new era of personalized immunotherapeutics.
Selected Works
ACS Nano
In Preparation
ACS Nano
Multi-Antigen T-Cell Hybridizers: A Two-Component T-Cell-Activating Therapy
Blood
In Preparation
ACS Nano
Two-Component T-Cell Immunotherapy Reduces Cytokine Release Without
Forfeiting Efficacy
In Preparation
In Preparation
In Preparation
Multi-specific Effector Cell Engagers
Team
Thomas Gambles, PhD
Jindřich Kopeček, PhD
Jindřich Kopeček, PhD
President & CEO
Jindřich Kopeček, PhD
Jindřich Kopeček, PhD
Jindřich Kopeček, PhD
Co-Founder
Shawn Owen, PhD
Jindřich Kopeček, PhD
Shawn Owen, PhD
Director
Isaac Kendell
Jiahui Li, PharmD
Shawn Owen, PhD
Technician
Jiahui Li, PharmD
Jiahui Li, PharmD
Jiahui Li, PharmD
Technician